MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Tremors: Treatment"

  • 2018 International Congress

    The complementary relationship between zonisamide and istradefylline in treating patients with Parkinson’s disease

    T. Kadowaki, M. Hamaguchi, H. Sakuramoto, T. Shiina, H. Fujita, K. Suzuki, K. Hirata (Mibu, Japan)

    Objective: To investigate patients with Parkinson’s disease (PD) who received zonisamide and istradefylline at the same period. Background: Zonisamide and istradefylline are anti-PD drugs with…
  • 2018 International Congress

    Bio-Electro Stimulation Therapy for the Treatment of Motor and Non-Motor Symptoms in Parkinson’s Disease

    T. Tsao, C. Fontana, A. Waite (Boston, MA, USA)

    Objective: Design an experiment to assess tremor severity comparable to the current clinical standard using Shimmer3 sensors. Investigate collected data to see if BEST intervention…
  • 2018 International Congress

    MRI-guided Focused Ultrasound thalamotomy for Multiple Sclerosis-associated tremor: A case report

    B. Fernández-Rodríguez, D. Urso, M. Monje, JA. Pineda-Pardo, M. del Álamo, R. Blazquez-Navarro, F. Hernández-Fernández, L. Vela, F. Alonso-Frech, R. Martínez-Fernández, J. Obeso (Móstoles, Spain)

    Objective: To describe the effect of VIM thalamotomy by MRI-guided Focused Ultrasound (MRIgFUS) on Multiple Sclerosis (MS) tremor in a single patient. Background: Tremor is…
  • 2018 International Congress

    Effects of MRI-guided Focused Ultrasound unilateral subthalamotomy on characteristics of EMG activity underlying reaction time and tapping test in Parkinson’s disease

    D. Urso, B. Fernández-Rodríguez, R. Rodríguez-Rojas, M. del Álamo, F. Hernández-Fernández, J. Pineda-Pardo, M. Dileone, G. Foffani, I. Obeso, C. Gasca-Salas, L. Vela, R. Martínez-Fernández, F. Alonso-Frech, J. Obeso (Móstoles, Spain)

    Objective: To assess the effect of MRI-guided Focused Ultrasound (MRIgFUS) unilateral subthalamotomy on Parkinson disease’s (PD) motor features through EMG movement analysis. Background: Recent evidence…
  • 2017 International Congress

    Wearable sensor-based therapy titration for Parkinson’s Disease

    R. Schmidt, D. Heldman, A. Hadley, D. Riley (Cleveland, OH, USA)

    Objective: To describe a home-based method for improved Parkinson’s therapy titration. Background: Many patients with Parkinson’s disease, due to the location of their residence or…
  • 2017 International Congress

    Closed Loop STN DBS for Tremor in Parkinson’s disease using a Neural or Kinematic Signal

    A. Velisar, J. Herron, J. SYRKIN-NIKOLAU, Z. Blumenfeld, M. TRAGER, T. MARTIN, H. CHIZECK, H. Bronte-Stewart (Palo Alto, CA, USA)

    Objective: Compare safety, tolerability, efficiency and efficacy of closed loop DBS (clDBS) of the subthalamic nucleus (STN) for resting tremor in Parkinson’s disease (PD) using…
  • 2017 International Congress

    Ultrasonography-guided Botulinum Toxin Type-A Injection in Tremor. An open-label Study

    H. Shehata, N. Shalaby, M. Basheer, A. Elmazny, S. Eljaafary (Cairo, Egypt)

    Objective: To assess the role of ultrasound-guided (US) Onabotulinumtoxin-A (BoNT-A) injections for various types of hand and head tremor. Background: Focal treatment of head and…
  • 2017 International Congress

    Cannabis and Parkinson’s Disease Tremor

    L. Mischley, R. Bennett, M. Sexton, G. Ricciardi, J. McNames (Kenmore, WA, USA)

    Objective: The purpose of this study was to describe the effect of Cannabis on Parkinson’s disease (PD) tremor using advanced motion detection technology and qualitative…
  • 2017 International Congress

    TETRAS applicability and study design in randomized, placebo controlled clinical trial of Cav3 modulation for essential tremor patients.

    Y. Maricich, E. Newbold, R. Elble (Charlottesville, VA, USA)

    Objective: We will study CX-8998, a selective Cav3 antagonist with safety data in 194 patients,  in the treatment of ET. Few large controlled ET trials…
  • 2017 International Congress

    Comparison of the effect of thalamic DBS/coagulation on tremor and thalamic neuronal activity in spinocerebellar ataxia and essential tremor

    T. Hashimoto, A. Muralidharan, K. Yoshida, T. Goto, T. Yako, K. Baker, J. Vitek (Matsumoto, Japan)

    Objective: To investigate the effects of deep brain stimulation (DBS) or lesions of the ventral intermediate nucleus (Vim) of the thalamus for spinocerebellar ataxia (SCA)…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 17
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley